Pharmaceutical Pricing and Reimbursement in the United StatesDecision ResourcesDecember 15, 2006 48 Pages - SKU: DECR1399804 |
| Countries covered: United States Introduction One of the most attractive features of the U.S. pharmaceutical market for manufacturers is the unrivaled freedom of its pricing and reimbursement environment. However, after many years of vigorous expansion, the U.S. pharmaceutical market has recently shown signs of a slowdown in its growth rate. Companies will need to give considerable thought to future pricing strategies in the United States. Questions Answered in This Spectrum Report On average, pharmaceutical prices in the United States are much higher than in Europe. How are pharmaceutical prices determined in the public and private sectors in the United States? Drugs administered by medical professionals require reimbursement for the costs of both the medicines themselves and the service of administering them. In an attempt to curb the inexorable growth in spending on these medications, third-party payers have developed complex systems for provider reimbursement. How are providers reimbursed for the costs of these drugs? Managed care organizations employ a wide range of demand-side cost-containment measures to curb pharmaceutical spending in the United States. What are the most widely used cost containment measures? Pharmacy benefit management companies (PBMs) play a pivotal role in the U.S. pharmaceutical market. PBMs administer the drug benefits of approximately 200 million U.S. residents. How do PBMs negotiate drug prices with pharmaceutical companies? How do PBMs impact prescription drug costs? Scope
|
Additional Information
Companies and Organizations Mentioned in This Spectrum Report
- Companies
- Amgen
- Avalere Health
- Bristol-Myers Squibb
- Caremark
- Dyckman & Associates
- Eli Lilly
- Express Scripts
- Genentech
- HealthLeaders-InterStudy
- Hewitt Associates
- ImClone Systems
- IMS Health
- Medco Health
- Merck
- PricewaterhouseCoopers
- Verispan
- Organizations
- American Medical Directors Association
- American Society of Consultant
- Pharmacists
- Health Research Educational Trust
- Kaiser Commission on Medicaid and the
- Uninsured
- Kaiser Family Foundation
- Organization for Economic Cooperation
- and Development
- Pharmaceutical Care Management
- Association
- Pharmacy & Therapeutics Society
More United States Pricing Reports
Pricing and Reimbursement in the US - Non-LIS Beneficiaries Not Covered by Medicare Coverage Gap to Gain from Reduction in Out-of-Pocket Expenditure for Generic Drugs by
GBI Research
Pricing and Reimbursement in the US - Non-LIS Beneficiaries Not Covered by Medicare Coverage Gap to Gain from Reduction in Out-of-Pocket Expenditure for Generic Drugs
...
US Pharmacy Benefit Management (PBM) Industry Report: 2011 Edition by
Koncept Analytics
PBM companies aim at merging retail pharmacy claims processing, formulary management and home delivery pharmacy services in order to develop and create an integrated product ...
Pharmaceutical Pricing, Reimbursement, and Market Access News in the Third Quarter of 2011 by
Decision Resources
In the third quarter of 2011, politicians in the United States, Europe, and Japan faced the unpleasant task of having to make substantial budget cuts. ...
Pharmaceutical Pricing, Reimbursement, and Market Access News in the First Quarter of 2011 by
Decision Resources
For the international pharmaceutical industry, 2011 began as 2010 ended, with governments in the United States, Europe, and Japan looking to cut costs in the ...
Healthcare Reform in the US - Impact on Pricing and Reimbursement by
GlobalData
Healthcare Reform in the US - Impact on Pricing and Reimbursement Summary On 23 March, 2010, the Obama administration brought into effect the Patient Protection and Affordable ...
See all reports like this >>
More United States Reports
e-Discovery Software Publishing in the US - Industry Market Research Report by
IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...
D&B Country RiskLine Report: The United States of America by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by
Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Country Report United States January 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
Coal - US - a snapshot (2010) by
Mintel - Snapshots
Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...
See all reports like this >>
Related Markets
Pricing Reports
- Pricing and Reimbursement in Generics - European Austerity Measures and Healthcare Cost Containment Puts Innovation-Driven Pharma Companies under Pressure
- Pricing and Reimbursement in Russia - Big Pharma Take Advantage of Reimbursement for Costly Drugs Through the DLO’s Seven Nosologies Program
- Pricing and Reimbursement of the Healthcare System in India - Low Levels of Drug Reimbursement Lead to a High Out-Of-Pocket Expenditure
- The Royalty Rate Report 2012: A Comprehensive Assessment of Valuation in the Pharmaceutical Sector
- Pharmaceutical Pricing Strategies – Changing Approaches to Meet Challenging Times
